HuGE Literature Finder
Records 1-30
|
Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
World journal of gastroenterology 2019 Jul 25 (26): 3408-3425. Wu Jing-Bo, Sarmiento Ali Lopez, Fiset Pierre-Olivier, Lazaris Anthula, Metrakos Peter, Petrillo Stephanie, Gao Zu-H |
|
Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.
Lung cancer (Amsterdam, Netherlands) 2019 Jul 133 144-150. Aredo Jacqueline V, Padda Sukhmani K, Kunder Christian A, Han Summer S, Neal Joel W, Shrager Joseph B, Wakelee Heather |
|
Association between Certain NSCLC Driver Mutations and Predictive Markers for Chemotherapy or PD-(L)1 Inhibition.
Cancer science 2019 Apr . Liang Wenhua, Guo Minzhang, Pan Zhenkui, Cai Xiuyu, Li Caichen, Zhao Yi, Liang Hengrui, Yang Haiying, Wang Zhen, Chen Wenting, Xu Chuhong, Yang Xinyun, Sun Jianyu, He Ping, Gu Xia, Yin Weiqiang, He Jianxi |
|
PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1.
Thoracic cancer 2019 01 10 (1): 103-110. Lee Jongmin, Park Chan Kwon, Yoon Hyoung-Kyu, Sa Young Jo, Woo In Sook, Kim Hyo Rim, Kim Sue Youn, Kim Tae-Ju |
|
Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations.
PloS one 2019 14 (4): e0215292. Sato Miyuki, Watanabe Satoshi, Tanaka Hiroshi, Nozaki Koichiro, Arita Masashi, Takahashi Miho, Shoji Satoshi, Ichikawa Kosuke, Kondo Rie, Aoki Nobumasa, Hayashi Masachika, Ohshima Yasuyoshi, Koya Toshiyuki, Ohashi Riuko, Ajioka Yoichi, Kikuchi Toshia |
|
Immune marker profiling and PD-L1 expression across Non-Small Cell Lung Cancer mutations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Sep . Toki Maria I, Mani Nikita, Smithy James W, Liu Yuting, Altan Mehmet, Wasserman Brad, Tuktamyshov Rasikh, Schalper Kurt, Syrigos Konstantinos N, Rimm David |
|
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Lung cancer (Amsterdam, Netherlands) 2018 Jul 121 70-75. Falk Alexander T, Yazbeck Nathalie, Guibert Nicolas, Chamorey Emmanuel, Paquet Agnès, Ribeyre Lydia, Bence Coraline, Zahaf Katia, Leroy Sylvie, Marquette Charles-Hugo, Cohen Charlotte, Mograbi Baharia, Mazières Julien, Hofman Véronique, Brest Patrick, Hofman Paul, Ilié Mari |
|
Strong PD-L1 expression predicts poor response and de novo resistance to EGFR TKIs among non-small cell lung cancer patients with EGFR mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Jul . Su Shan, Dong Zhong-Yi, Xie Zhi, Yan Li-Xu, Li Yu-Fa, Su Jian, Liu Si-Yang, Yin Kai, Chen Rui-Lian, Huang Shu-Mei, Chen Zhi-Hong, Yang Jin-Ji, Tu Hai-Yan, Zhou Qing, Zhong Wen-Zhao, Zhang Xu-Chao, Wu Yi-Lo |
|
Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small-Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2018 May . Higgs Brandon W, Morehouse Christopher, Streicher Katie L, Brohawn Philip, Pilataxi Fernanda, Gupta Ashok, Ranade Koustu |
|
Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 57-61. Song Zhengbo, Cheng Guoping, Xu Chunwei, Wang Wenxian, Shao Yang, Zhang Yipi |
|
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Molecular cancer 2018 Apr 17 (1): 81. Liu Liang, Ruiz Jimmy, O'Neill Stacey S, Grant Stefan C, Petty W Jeffrey, Yang Meng, Chen Kexin, Topaloglu Umit, Pasche Boris, Zhang W |
|
A genetic polymorphism in CTLA-4 is associated with overall survival in sunitinib-treated patients with clear cell metastatic renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Feb . Liu Xiaoyan, Swen Jesse J, Diekstra Meta H M, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron Hj, Vermeulen Sita H, Oosterwijk Egbert, Junker Kerstin, Roessler Max, Alexiusdottir Kristin, Sverrisdottir Asgerdur, Radu Marius T, Ambert Valentin, Eisen Timothy, Warren Anne Y, Rodríguez-Antona Cristina, García-Donás Jesus, Koudijs Karel K M, Böhringer Stefan, Kiemeney Lambertus A, Rini Brian, Guchelaar Henk-J |
|
Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
Clinical lung cancer 2018 Feb . Petrelli Fausto, Maltese Mariangela, Tomasello Gianluca, Conti Barbara, Borgonovo Karen, Cabiddu Mary, Ghilardi Mara, Ghidini Michele, Passalacqua Rodolfo, Barni Sandro, Brighenti Matt |
|
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Science (New York, N.Y.) 2018 Jan . Miao Diana, Margolis Claire A, Gao Wenhua, Voss Martin H, Li Wei, Martini Dylan J, Norton Craig, Bossé Dominick, Wankowicz Stephanie M, Cullen Dana, Horak Christine, Wind-Rotolo Megan, Tracy Adam, Giannakis Marios, Hodi Frank Stephen, Drake Charles G, Ball Mark W, Allaf Mohamad E, Snyder Alexandra, Hellmann Matthew D, Ho Thai, Motzer Robert J, Signoretti Sabina, Kaelin William G, Choueiri Toni K, Van Allen Eliezer |
|
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
Clinical lung cancer 2018 07 19 (4): e441-e463. Reis Henning, Metzenmacher Martin, Goetz Moritz, Savvidou Nikoleta, Darwiche Kaid, Aigner Clemens, Herold Thomas, Eberhardt Wilfried E, Skiba Charlotte, Hense Jörg, Virchow Isabel, Westerwick Daniela, Bogner Simon, Ting Saskia, Kasper Stefan, Stuschke Martin, Nensa Felix, Herrmann Ken, Hager Thomas, Schmid Kurt W, Schuler Martin, Wiesweg Marc |
|
Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression.
Anticancer research 2018 02 38 (2): 753-762. Kobayashi Kenichi, Seike Masahiro, Zou Fenfei, Noro Rintaro, Chiba Mika, Ishikawa Arimi, Kunugi Shinobu, Kubota Kaoru, Gemma Akihi |
|
Programmed death-ligand 1 expression and CD8+ tumor-infiltrating lymphocytes in advanced non-small cell lung cancer treated with microwave ablation and chemotherapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2018 35 (1): 591-598. Wei Zhigang, Zhan Xuemei, Fan Linlin, Ye Xin, Yang Xia, Huang Guanghui, Li Wenhong, Wang Jiao, Han Xiaoying, Meng Min, Ni Yang, Li Qing |
|
Mutational Diversity of Lung Cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2.
Pathology oncology research : POR 2017 Nov . Legras Antoine, Roussel Hélène, Mangiameli Giuseppe, Arame Alex, Grand Bertrand, Pricopi Ciprian, Badia Alain, Gibault Laure, Badoual Cécile, Fabre Elizabeth, Laurent-Puig Pierre, Blons Hélène, Le Pimpec-Barthes Françoi |
|
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research.
Clinical genitourinary cancer 2017 Oct . Necchi Andrea, Lo Vullo Salvatore, Giannatempo Patrizia, Raggi Daniele, Perrone Federica, Nicolai Nicola, Catanzaro Mario, Biasoni Davide, Torelli Tullio, Piva Luigi, Stagni Silvia, Salvioni Roberto, Mariani Luigi, Colecchia Mauriz |
|
Programmed death-1 lignd-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers.
Cancer biomarkers : section A of Disease markers 2017 Oct . Zhou Rong-Miao, Li Yan, Liu Jiang-Hui, Wang Na, Huang Xi, Cao Shi-Ru, Shan Bao- |
|
Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2017 Sep 111 182-189. Hata Akito, Katakami Nobuyuki, Nanjo Shigeki, Okuda Chiyuki, Kaji Reiko, Masago Katsuhiro, Fujita Shiro, Yoshida Hiroshi, Zama Kota, Imai Yukihiro, Hirata Yuk |
|
A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.
Journal of thoracic disease 2017 Aug 9 (8): 2560-2571. Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang |
|
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Human pathology 2017 Aug . Yeo Min-Kyung, Choi Song-Yi, Seong In-Ock, Suh Kwang-Sun, Kim Jin Man, Kim Kyung-H |
|
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Aug 28 (8): 1934-1941. Foy J-P, Bertolus C, Michallet M-C, Deneuve S, Incitti R, Bendriss-Vermare N, Albaret M-A, Ortiz-Cuaran S, Thomas E, Colombe A, Py C, Gadot N, Michot J-P, Fayette J, Viari A, Van den Eynde B, Goudot P, Devouassoux-Shisheboran M, Puisieux A, Caux C, Zrounba P, Lantuejoul S, Saintigny |
|
Variant SNPs at the microRNA complementary site in the B7?H1 3'?untranslated region increase the risk of non?small cell lung cancer.
Molecular medicine reports 2017 Jun . Du Wenwen, Zhu Jianjie, Chen Yanbin, Zeng Yuanyuan, Shen Dan, Zhang Nan, Ning Weiwei, Liu Zeyi, Huang Jian- |
|
The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC.
Oncotarget 2017 Apr 8 (14): 23517-23528. Yang Haitao, Chen Huijuan, Luo Shuimei, Li Lina, Zhou Sijing, Shen Ruifen, Lin Heng, Xie Xian |
|
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
Scientific reports 2017 Mar 7 45124. Nomizo Takashi, Ozasa Hiroaki, Tsuji Takahiro, Funazo Tomoko, Yasuda Yuto, Yoshida Hironori, Yagi Yoshitaka, Sakamori Yuichi, Nagai Hiroki, Hirai Toyohiro, Kim Young H |
|
Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
Gastroenterology 2017 Mar . Zhang Weilong, He Huan, Zang Mengya, Wu Qifeng, Zhao Hong, Lu Ling-Ling, Ma Peiqing, Zheng Hongwei, Wang Nengjin, Zhang Ying, He Siyuan, Chen Xiaoyan, Wu Zhiyuan, Wang Xiaoyue, Cai Jianqiang, Liu Zhihua, Sun Zongtang, Zeng Yi-Xin, Qu Chunfeng, Jiao Yuch |
|
Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
Gene 2017 Jan 599 28-35. Lee Shin Yup, Jung Deuk Kju, Choi Jin Eun, Jin Cheng Cheng, Hong Mi Jeong, Do Sook Kyung, Kang Hyo-Gyoung, Lee Won Kee, Seok Yangki, Lee Eung Bae, Jeong Ji Yun, Shin Kyung Min, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
|
Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
Oncology research and treatment 2017 40 (1-2): 7-13. Igawa Satoshi, Ryuge Shiichiro, Ichinoe Masaaki, Nakashima Hiroyasu, Otani Sakiko, Nakahara Yoshiro, Fukui Tomoya, Sasaki Jiichiro, Kubota Masaru, Katagiri Masato, Murakumo Yoshiki, Satoh Yukitoshi, Sato Yuichi, Masuda Noriyu |
|
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Nov 11 (11): 1869-1878. Huynh Tiffany G, Morales-Oyarvide Vicente, Campo Meghan J, Gainor Justin F, Bozkurtlar Emine, Uruga Hironori, Zhao Ling, Gomez-Caraballo Maria, Hata Aaron N, Mark Eugene J, Lanuti Michael, Engelman Jeffrey A, Mino-Kenudson Ma |
|
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
The New England journal of medicine 2016 Oct . Reck Martin, Rodríguez-Abreu Delvys, Robinson Andrew G, Hui Rina, Cs?szi Tibor, Fülöp Andrea, Gottfried Maya, Peled Nir, Tafreshi Ali, Cuffe Sinead, O'Brien Mary, Rao Suman, Hotta Katsuyuki, Leiby Melanie A, Lubiniecki Gregory M, Shentu Yue, Rangwala Reshma, Brahmer Julie R, |
|
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology 2016 Sep . Kadara H, Choi M, Zhang J, Cuentas E P, Canales J R, Gaffney S G, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons D L, Heymach J, Kaftan E, Townsend J P, Lynch T J, Schlessinger J, Lee J, Lifton R P, Wistuba I I, Herbst R |
|
[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?]
Bulletin du cancer 2016 Jun . Dreyer Chantal, Afchain Pauline, Trouilloud Isabelle, André Thier |
|
Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Jun . Takada Kazuki, Okamoto Tatsuro, Shoji Fumihiro, Shimokawa Mototsugu, Akamine Takaki, Takamori Shinkichi, Katsura Masakazu, Suzuki Yuzo, Fujishita Takatoshi, Toyokawa Gouji, Morodomi Yosuke, Okano Shinji, Oda Yoshinao, Maehara Yoshihi |
|
Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 May 26 (4): 648-54. Friedlander Michael L, Russell Kenneth, Millis Sherri, Gatalica Zoran, Bender Ryan, Voss Andre |
|
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
Gut 2016 May . Masugi Yohei, Nishihara Reiko, Yang Juhong, Mima Kosuke, da Silva Annacarolina, Shi Yan, Inamura Kentaro, Cao Yin, Song Mingyang, Nowak Jonathan A, Liao Xiaoyun, Nosho Katsuhiko, Chan Andrew T, Giannakis Marios, Bass Adam J, Hodi F Stephen, Freeman Gordon J, Rodig Scott, Fuchs Charles S, Qian Zhi Rong, Ogino Shu |
|
PD-1/PD-L1 expression in non-small-cell lung cancer and its correlation with EGFR/KRAS mutations.
Cancer biology & therapy 2016 Mar 0. Ji Mei, Liu Yan, Li Qing, Li Xiaodong, Ning Zhonghua, Zhao Weiqing, Shi Hongbing, Jiang Jingting, Wu Changpi |
|
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2016 Feb 57 91-103. Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Ch |
|
Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Lung cancer (Amsterdam, Netherlands) 2016 Jan 91 7-14. Saruwatari Koichi, Ikemura Shinnosuke, Sekihara Keigo, Kuwata Takeshi, Fujii Satoshi, Umemura Shigeki, Kirita Keisuke, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Ochiai Atsushi, Kohrogi Hirotsugu, Tsuboi Masahiro, Goto Koichi, Ishii Genichi |
|
PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy.
Scientific reports 2016 6 25952. Lee Shin Yup, Jung Deuk Kju, Choi Jin Eun, Jin Cheng Cheng, Hong Mi Jeong, Do Sook Kyung, Kang Hyo-Gyoung, Lee Won Kee, Seok Yangki, Lee Eung Bae, Jeong Ji Yun, Shin Kyung Min, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
|
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
Journal of translational medicine 2016 06 14 (1): 188. Song Zhengbo, Yu Xinmin, Cheng Guoping, Zhang Yipi |
|
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
European urology 2015 Dec . Messai Yosra, Gad Sophie, Noman Muhammad Zaeem, Le Teuff Gwenael, Couve Sophie, Janji Bassam, Kammerer Solenne Florence, Rioux-Leclerc Nathalie, Hasmim Meriem, Ferlicot Sophie, Baud Véronique, Mejean Arnaud, Mole David Robert, Richard Stéphane, Eggermont Alexander M M, Albiges Laurence, Mami-Chouaib Fathia, Escudier Bernard, Chouaib Sal |
|
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Cancer research 2015 Dec . Wong Stephen Q, Waldeck Kelly, Vergara Ismael A, Schröder Jan, Madore Jason, Wilmott James S, Colebatch Andrew J, De Paoli-Iseppi Ricardo, Li Jason, Lupat Richard, Semple Timothy, Arnau Gisela Mir, Fellowes Andrew, Leonard J Helen, Hruby George, Mann Graham J, Thompson John F, Cullinane Carleen, Johnston Meredith, Shackleton Mark, Sandhu Shahneen, Bowtell David D L, Johnstone Ricky W, Fox Stephen B, McArthur Grant A, Papenfuss Anthony T, Scolyer Richard A, Gill Anthony J, Hicks Rodney J, Tothill Richard |
|
PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer.
The International journal of biological markers 2015 Sep 0. Cheng Sensen, Zheng Jinsong, Zhu Jingyan, Xie Chao, Zhang Xia, Han Xiao, Song Bao, Ma Yuan, Liu J |
|
Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma.
Clinical lung cancer 2015 Sep 16 (5): e25-35. Lin Cheng, Chen Xiong, Li Meifang, Liu Jingnan, Qi Xingfeng, Yang Wenting, Zhang Hairong, Cai Zhongfu, Dai Yun, Ouyang Xueno |
|
Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets.
Pathology oncology research : POR 2015 Jul 21 (3): 695-701. Wu Hao, Sun Yue, Ye Huihui, Yang Shi, Lee Stephanie L, de las Morenas Anton |
|
The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.
Oncotarget 2015 Jun 6 (16): 14209-19. Tang Yanna, Fang Wenfeng, Zhang Yaxiong, Hong Shaodong, Kang Shiyang, Yan Yue, Chen Nan, Zhan Jianhua, He Xiaobo, Qin Tao, Li Ge, Tang Wenyi, Peng Peijian, Zhang |
|
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Jun 10 (6): 910-23. Chen Nan, Fang Wenfeng, Zhan Jianhua, Hong Shaodong, Tang Yanna, Kang Shiyang, Zhang Yaxiong, He Xiaobo, Zhou Ting, Qin Tao, Huang Yan, Yi Xianping, Zhang |
|
A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma.
Human genetics 2013 Jun 132 (6): 641-8. Wang Weipeng, Li Fang, Mao Yong, Zhou Huan, Sun Jing, Li Rui, Liu Cuiping, Chen Weichang, Hua Dong, Zhang Xuegua |
|
Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.
Asia-Pacific journal of clinical oncology 2012 Nov . Chen YB, Mu CY, Chen C, Huang JA |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jul 10, 2020
- Content source: